Riskpilot← Back to searchSign inGet full accessProlight Diagnostics AB (publ)
ABActiveOrg 5565709499Magistratsvägen 10Manufacture of other organic basic chemicals · NACE 2014Est. 19990 employees
Revenue 2024
SEK 0
EBITDA margin
—
+95% vs 2023
Equity ratio
81.4%
Financial strength
Net profit 2024
SEK -47,6M
+69% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -6,2M | +95% |
| Net profit | SEK -47,6M | +69% |
| Total assets | SEK 85,8M | -23% |
| Equity | SEK 69,8M | -27% |
| Employees | 0 | — |
Legal name
Prolight Diagnostics AB (publ)
Org number
5565709499
Legal form
Aktiebolag
NACE code
2014 · Manufacture of other organic basic chemicals
Founded
18 maj 1999
Share capital
SEK 70 209 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva tillverkning och försäljning av finkemikalier samt bioteknisk forskning och utveckling inom enzymhantering och biosensorer, samt därmed förenlig verksamhet.
Address
Magistratsvägen 10
Phone
+4646162070
Email
ub@prolightdx.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −2 137 | −2 040 | −2 983 | −5 811 | −4 366 | −4 181 | −6 972 | −8 138 | −120 212 | −6 177 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −2 137 | −2 040 | −2 983 | −5 811 | −4 366 | −4 181 | −6 972 | −8 138 | −120 212 | −6 177 |
| Net financials | −8 | −16 | 133 | −46 | 234 | −119 | 117 | −22 306 | −66 372 | −41 398 |
| Profit before tax | −2 146 | −2 056 | −2 850 | −5 857 | −4 132 | −4 300 | −6 855 | −30 443 | −153 129 | −47 575 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −2 146 | −2 056 | −2 850 | −5 857 | −4 132 | −4 300 | −6 855 | −30 443 | −153 129 | −47 575 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 17 733 | 42 186 | 37 119 | 86 187 | 103 974 | 154 346 | 149 133 | 187 729 | 111 570 | 85 792 |
| Equity | 17 360 | 35 111 | 36 454 | 82 019 | 100 759 | 153 165 | 146 309 | 186 257 | 96 244 | 69 801 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 373 | 7 075 | 665 | 4 168 | 3 215 | 1 181 | 2 824 | 1 472 | 15 325 | 15 991 |
| Total debt | 373 | 7 075 | 665 | 4 168 | 3 215 | 1 181 | 2 824 | 1 472 | 15 325 | 15 991 |
EBITDA margin
-617700000.0%
This company
15.8%
Market median
-3909493771% vs market
20152024
Equity ratio
81.4%
This company
38.2%
Market median
+113% vs market
20152024
Return on equity
-68.2%
This company
18.4%
Market median
-471% vs market
20152024
Net profit margin
-4757500000.0%
This company
8.1%
Market median
-58734568001% vs market
20152024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152024
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AH Chief Auditor | Chief Auditor | 2020 | — | — |
US Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
CA Chief Auditor | Chief Auditor | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Chairman | 2022 | — | — | |
| Chairman | 2020 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2024 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Prolight Diagnostics AB (publ) (this company)
PSYROS DIAGNOSTICS LTDPsyros Diagnostics LtdBoard members of Prolight Diagnostics AB (publ) also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Andreas Henrik Alexander Brodström | Chief Auditor | 0 companies |
| Ulf Sten Bladin | Chief Executive Officer | 0 companies |
| Curt Arne Jesper Ahlkvist | Chief Auditor | 0 companies |
| Steve Andrew Ross | Board of Directors | 0 companies |
| Aileen Jane McGettrick | Board of Directors | 0 companies |
| Tobias Tjis Volker | Board of Directors | 0 companies |
| Maria Brigitte Holmlund | Board of Directors | 0 companies |
| Masoud Khayyami | Chairman | 0 companies |
| Gustav Ingemar Kihlström | Chairman | 0 companies |
| Mats Olof Gustaf Persson | Chairman | 0 companies |
| Fredrik Veimar Alpsten | Chairman | 0 companies |
| Kiarash Moaierifar | Board of Directors | 0 companies |